Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Venetoclax (Ven) with Azacitidine (Aza) for Untreated Elderly Acute Myeloid Leukemia (AML) Patients (Pts) Unfit for Induction Chemotherapy: Single Center Clinical Experience and Mechanistic Insights from Correlative Studies

Daniel A. Pollyea, MD, Brett M. Stevens, PhD, Amanda Winters, MD PhD, Mohd Minhajuddin, PhD, Jonathan A Gutman, MD, Enkhtsetseg Purev, MD PhD, Clayton Smith, MD FRCPC, Diana Abbott, PhD, Craig T. Jordan, PhD

Blood (2017) 130 (Supplement 1): 181.

https://doi.org/10.1182/blood.V130.Suppl_1.181.181

Published: 2017

Journal Articles

Post-Transplant Diffuse Large B Cell Lymphoma with Non Germinal Center B-Cell Subtype Frequently Lacks Programmed Cell Death Ligand (PD-L1) Overexpression Which May Influence Overall Outcomes

Zohra Nooruddin, MD, Zenggang Pan, MD PhD, Lilyana Gross, Weitzenkamp David, Bradley M. Haverkos, MD MPH, MS, Daniel A Pollyea, MD, Jonathan A Gutman, MD, William Robinson, MD PhD, Clayton Smith, MD FRCPC, Jeffrey Schowinsky, MD, Purev Enkhtsetseg, MD, Daniel W. Sherbenou, MD PhD, Rachel Rabinovitch, MD, Douglas Ney, MD, Craig T Jordan, PhD, Manali Kamdar, MD

Blood (2016) 128 (22): 3054.

https://doi.org/10.1182/blood.V128.22.3054.3054

Published: 2016

Journal Articles

IHC Analysis and Prognostic Factors in Post Transplant Lymphoproliferative Disorders after Solid Organ Transplantation: A Single Center Experience

Zohra Nooruddin, MD, William Robinson, MD PhD, Daniel Pollyea, MD MS, Jonathan A Gutman, MD, Clayton Smith, MD FRCPC, Zenggang Pan, MD, Craig T Jordan, PhD, Rachel Rabinovitch, MD, Jeffrey Schowinsky, Xian Lu, PhD, Douglas Ney, MD, Manali Kamdar, MD

Blood (2015) 126 (23): 1443.

https://doi.org/10.1182/blood.V126.23.1443.1443

Published: 2015

Journal Articles

High Incidence of Invasive Fungal Infections in Adult Patients Undergoing Hematopoietic Stem Cell Transplantation.

Winnie Ma, BSc(Pharm), Dawn Warkentin, BSc(Pharm), PharmD, Janice Yeung, BSc(Pharm), PharmD, John D Shepherd, MD, Yasser Abou Mourad, MD, Clayton Smith, MD, FRCPC, Kevin Song, MD, Donna E. Hogge, MD, PhD, Michael J Barnett, BMBS, Thomas J. Nevill, MD, FRCPC, Stephen H. Nantel, MD, FRCPC, Cynthia L. Toze, MD, FRCP(C), Heather J. Sutherland, MD, PhD, Donna L. Forrest, MD, Sujaatha Narayanan, MD, Maryse M Power, MD

Blood (2009) 114 (22): 1136.

https://doi.org/10.1182/blood.V114.22.1136.1136

Published: 2009

Journal Articles

Exposure to Novel Agents Increases Post Relapse Survival in Patients with High Risk Myeloma Defined by Early Relapse (<12 months).

Christopher P. Venner, BSc, MD, Joseph M. Connors, MD, Heather J. Sutherland, MD, PhD, John D. Shepherd, MD, Linda Hamata, Yasser Abou Mourad, MD, Michael J Barnett, BMBS, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Stephen H. Nantel, MD, FRCPC, Sujaatha Narayanan, Thomas J. Nevill, MD, FRCPC, Janet Nitta, Maryse M Power, Cynthia L. Toze, MD, FRCP(C), Clayton Smith, MD, FRCPC, Kevin Song, MD

Blood (2009) 114 (22): 2872.

https://doi.org/10.1182/blood.V114.22.2872.2872

Published: 2009

Journal Articles

Impact of Comorbidity Index on Outcome with Allogeneic Hematopoetic Stem Cell Transplantation for Chronic Lymphocytic Leukemia

Cynthia L. Toze, MD, FRCP(C), Rauvynne N Sangara, Joseph M. Connors, MD, Thomas J. Nevill, MD, FRCPC, John D. Shepherd, MD, Julye Lavoie, MD, Michael J Barnett, BMBS, Stephen H. Nantel, MD, FRCPC, Nicholas Voss, MD, Donna E. Hogge, MD, PhD, Heather J. Sutherland, MD, PhD, Donna L Forrest, Kevin W Song, Yasser Abou Mourad, Maryse M Power, Sujaatha Narayanan, Ryan Brinkman, PhD, Clayton Smith, MD, FRCPC

Blood (2008) 112 (11): 3305.

https://doi.org/10.1182/blood.V112.11.3305.3305

Published: 2008

Journal Articles

New Candidate Regulators of Hematopoietic Stem Cells Identified from Transcriptional Comparisons of Highly Purified Populations of Longterm Repopulating Cells with Markedly Different in Vivo Self-Renewal Activities

David G Kent, BSc, Michael R Copley, B.Sc., Claudia Benz, PhD, Brad J Dykstra, PhD, Elaine Ma, BSc, Jay Cheyne, BSc, Yongjun Zhao, MSc, Maura Gasparetto, MD, Allen Delaney, PhD, Clayton Smith, MD, FRCPC, Marco Marra, PhD, Connie J. Eaves, PhD

Blood (2008) 112 (11): 2460.

https://doi.org/10.1182/blood.V112.11.2460.2460

Published: 2008

NARROW

Venetoclax (Ven) with Azacitidine (Aza) for Untreated Elderly Acute Myeloid Leukemia (AML) Patients (Pts) Unfit for Induction Chemotherapy: Single Center Clinical Experience and Mechanistic Insights from Correlative Studies

Post-Transplant Diffuse Large B Cell Lymphoma with Non Germinal Center B-Cell Subtype Frequently Lacks Programmed Cell Death Ligand (PD-L1) Overexpression Which May Influence Overall Outcomes

IHC Analysis and Prognostic Factors in Post Transplant Lymphoproliferative Disorders after Solid Organ Transplantation: A Single Center Experience

High Incidence of Invasive Fungal Infections in Adult Patients Undergoing Hematopoietic Stem Cell Transplantation.

Exposure to Novel Agents Increases Post Relapse Survival in Patients with High Risk Myeloma Defined by Early Relapse (<12 months).

Impact of Comorbidity Index on Outcome with Allogeneic Hematopoetic Stem Cell Transplantation for Chronic Lymphocytic Leukemia

New Candidate Regulators of Hematopoietic Stem Cells Identified from Transcriptional Comparisons of Highly Purified Populations of Longterm Repopulating Cells with Markedly Different in Vivo Self-Renewal Activities

Email alerts

ASH Publications

American Society of Hematology

Venetoclax (Ven) with Azacitidine (Aza) for Untreated Elderly Acute Myeloid Leukemia (AML) Patients (Pts) Unfit for Induction Chemotherapy: Single Center Clinical Experience and Mechanistic Insights from Correlative Studies

Post-Transplant Diffuse Large B Cell Lymphoma with Non Germinal Center B-Cell Subtype Frequently Lacks Programmed Cell Death Ligand (PD-L1) Overexpression Which May Influence Overall Outcomes

IHC Analysis and Prognostic Factors in Post Transplant Lymphoproliferative Disorders after Solid Organ Transplantation: A Single Center Experience

High Incidence of Invasive Fungal Infections in Adult Patients Undergoing Hematopoietic Stem Cell Transplantation.

Exposure to Novel Agents Increases Post Relapse Survival in Patients with High Risk Myeloma Defined by Early Relapse (<12 months).

Impact of Comorbidity Index on Outcome with Allogeneic Hematopoetic Stem Cell Transplantation for Chronic Lymphocytic Leukemia

New Candidate Regulators of Hematopoietic Stem Cells Identified from Transcriptional Comparisons of Highly Purified Populations of Longterm Repopulating Cells with Markedly Different in Vivo Self-Renewal Activities

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only